Save time and money with
Med Tech Market Research


MedTech Business intelligence
supplied through Trade Tracker, Research and Markets and GlobalData

Bioinformatics Markets

Strategies, Business Models and Trends for the Future

Publication Date: March 2009
Publisher: TriMark Publications
Pages: 224

Price £2,350.00
approximately: $3,403 | €2,504

Buy now >>
(managed by Piribo)

The life science informatics marketplace — known as bioinformatics — is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies.

TriMark Publications believes that many of the segments of bioinformatics described in this report offer an unusual opportunity for accelerated expansion within the coming years.

This study is arranged to provide an overview of bioinformatics market segments and offer evidence that these segments are poised for significant future growth.

Each segment is accompanied by analysis and forecasts by product type and application. This analysis surveys the bioinformatics market and the latest information regarding emerging new products and industry trends. The study will quantify and qualify the bioinformatics market segments as an area of research, product development and investment.

Forecasts of the bioinformatics market and an analysis of products in the worldwide information-processing market will provide a basis for understanding the significance of past developments and future possibilities within this market category.

Buy now >>
(managed by Piribo)

Contents

  • 1. Overview
    • 1.1 Statement of Report
    • 1.2 About this Report
    • 1.3 Scope of this Report
    • 1.4 Methodology
    • 1.5 Executive Summary
  • 2. Introduction
    • 2.1 Global Bioinformatics Products Industry
    • 2.2 Computers and Biology
    • 2.3 Bioinformatics and the Internet
    • 2.4 Company Evaluation Overview
    • 2.5 Market Outlook
    • 2.6 Competitive Structure
    • 2.7 Applications of Bioinformatics
      • 2.7.1 Medicine
      • 2.7.2 Microbial Genomics
      • 2.7.3 Agriculture
    • 2.8 R&D
      • 2.8.1 Allocation of R&D
      • 2.8.2 Traditional Drug Discovery Process
      • 2.8.3 Drug Discovery and Bioinformatics
      • 2.8.4 Collaborative Agreements
    • 2.9 The Human Genome Project (HGP)
      • 2.9.1 Goals of the Human Genome Project
      • 2.9.2 Benefits of the Human Genome Project
    • 2.10 Barriers to Entry
    • 2.11 Proteomics and Databases
      • 2.11.1 Protein Database Standards
      • 2.11.2 Future Trends
  • 3. The U.S. Bioinformatics Market
    • 3.1 Overview
    • 3.2 Market Restraints and Drivers
      • 3.2.1 Market Restraints
      • 3.2.2 Market Drivers
  • 4. Genomics
    • 4.1 The Biotechnology Industry
    • 4.2 The Development of a Genomics Market
      • 4.2.1 Market Drivers
      • 4.2.2 Market Restraints
      • 4.2.3 Market Size and Growth Projections
      • 4.2.4 The U.S. Genomics Market
    • 4.3 Biochips and DNA Microarrays
      • 4.3.1 Key Challenges
      • 4.3.2 Freeware
      • 4.3.3 New Tools
    • 4.4 Bioinformatics
    • 4.5 Disease Targets
    • 4.6 Functional Genomics
    • 4.7 Gene Sequencing
    • 4.8 Gene Sequence Variation Detection
    • 4.9 Comparative Genomics
    • 4.10 Genome Database Arrays
    • 4.11 High-throughput Genomics
      • 4.11.1 High-throughput Technology
      • 4.11.2 Lab on a Chip
    • 4.12 Pharmacogenomics
    • 4.13 Probe Arrays
      • 4.13.1 Gene Expression Monitoring Arrays
      • 4.13.2 DNA Analysis Arrays
    • 4.14 Proteomics
    • 4.15 Sequencing
    • 4.16 Single Nucleotide Polymorphisms (SNPs)
    • 4.17 Structural Genomics
    • 4.18 Photolithography
    • 4.19 Instrumentation
  • 5. The Bioinformatics Industry
    • 5.1 Definition and Role of Bioinformatics
      • 5.1.1 Bioinformatics Sector Overview
      • 5.1.2 The Future Status of Bioinformatics
      • 5.1.3 Barriers to Growth
    • 5.2 Types of Data and Bioinformatics Applications
      • 5.2.1 Validated Core Modeling Technology
      • 5.2.2 Broad Applicability
      • 5.2.3 Data Management Compliant with Industry Standards
      • 5.2.4 Open Architecture
      • 5.2.5 Ease of Use
      • 5.2.6 Increased Access
    • 5.3 Functions of Bioinformatics Software
      • 5.3.1 Data Management
      • 5.3.2 Data Transformation
      • 5.3.3 Data Collaboration
      • 5.3.4 Interface for Online Data Sources
    • 5.4 Target Markets for Informatics Software
    • 5.5 Steps Involved in Bringing a Drug to Market
    • 5.6 Costs Incurred in Developing a New Drug
    • 5.7 Industry Drivers and Challenges
    • 5.8 Industry Risks
    • 5.9 Products of Bioinformatics
    • 5.10 Bioinformatics Processes
    • 5.11 Informatics Tools and Functionalities
      • 5.11.1 Sequence to Structure
      • 5.11.2 Lead Identification and Optimization
      • 5.11.3 Development and Formulation
      • 5.11.4 Improving Materials and Processes
      • 5.11.5 Other Materials-Based Industries
    • 5.12 Role of Bioinformatics in the Biotechnology Value Chain
    • 5.13 Bioinformatics Market Segment
      • 5.13.1 Databases
      • 5.13.2 Hardware
      • 5.13.3 Software
      • 5.13.4 Bioinformatics Services
    • 5.14 Bioinformatics Market Size
      • 5.14.1 Sales and R&D
      • 5.14.2 IT Budget
      • 5.14.3 Projected Bioinformatics Market Size
    • 5.15 Global Market Perspective
  • 6. Bioinformatics Business
    • 6.1 Bioinformatics Business Models
      • 6.1.1 Changing Business Models
      • 6.1.2 Competition for Pure Play Informatics Companies
      • 6.1.3 Non-Profit Organizations
      • 6.1.4 In-House Bioinformatics Solutions
      • 6.1.5 Large IT Companies
    • 6.2 Bioinformatics Target Disciplines
      • 6.2.1 Comparative Genomics
      • 6.2.2 Pharmacogenomics
      • 6.2.3 Functional Genomics
      • 6.2.4 Proteomics
      • 6.2.5 Structural Genomics
      • 6.2.6 Image Informatics
      • 6.2.7 Clinical Trial Informatics
      • 6.2.8 Cheminformatics
    • 6.3 Bioinformatics Architecture
    • 6.4 Bioinformatics Applications
      • 6.4.1 Data Search Tools
      • 6.4.2 Data Visualization Tools
      • 6.4.3 Data Mining and Clustering
      • 6.4.4 Enterprise Solutions
      • 6.4.5 Data Warehousing
    • 6.5 Evaluation of Bioinformatics Solutions
      • 6.5.1 Requirements of Study
      • 6.5.2 Shortlisting the Options
      • 6.5.3 Scoring Patterns
      • 6.5.4 Performance
      • 6.5.5 Data Storage
      • 6.5.6 Data Management in Drug Discovery
      • 6.5.7 Key Issues in Bioinformatics Data Storage
    • 6.6 Convergence of Industries
    • 6.7 Proteins as a Driver
    • 6.8 Current Bioinformatics Research
    • 6.9 New Bioinformatics Modeling Algorithms
    • 6.10 3D Modeling
    • 6.11 Patenting Bioinformatics Algorithms
  • 7. Recent Industry Activity
    • 7.1 Collaborations and Acquisitions
    • 7.2 Product Development and Launches
  • 8. Corporate Profiles
    • 8.1 Abbott Laboratories
    • 8.2 Abgenix
    • 8.3 Ablynx
    • 8.4 Accelrys
    • 8.5 Affimed Therapeutics
    • 8.6 Affitech
    • 8.7 Affymetrix
    • 8.8 Agencourt Bioscience Corporation
    • 8.9 Agensys
    • 8.10 Agilent Technologies
    • 8.11 Alexion Pharmaceuticals
    • 8.12 AlgoNomics
    • 8.13 ALLEZ Software
    • 8.14 Amgen
    • 8.15 Antisoma
    • 8.16 Applied Biosystems
    • 8.17 Arana Therapeutics
    • 8.18 Ariadne Genomics
    • 8.19 Array Genetics
    • 8.20 Astellas Pharma
    • 8.21 AstraZeneca
    • 8.22 Automated Handling Systems
    • 8.23 Avesthagen, Limited
    • 8.24 Bioalma
    • 8.25 BIOBASE Biological Databases
    • 8.26 BioCarta
    • 8.27 Biodatabases (AMITA Corporation)
    • 8.28 BioDiscovery
    • 8.29 Biogen Idec
    • 8.30 BioInformatics
    • 8.31 BioInformatics Services
    • 8.32 BioInformatics Solutions
    • 8.33 Biomax Informatics
    • 8.34 BioServe Technologies
    • 8.35 Biosiris
    • 8.36 BioSoftSolutions
    • 8.37 Biotique Systems
    • 8.38 BioInvent International
    • 8.39 Biosite Discovery
    • 8.40 BioWa
    • 8.41 BioWisdom
    • 8.42 Bio-Xtal
    • 8.43 Boehringer Ingelheim
    • 8.44 Cambridge Antibody Technology Group
    • 8.45 Capital Genomix
    • 8.46 Celera Group
    • 8.47 Cellectis
    • 8.48 Cellomics
    • 8.49 CeuticalSoft
    • 8.50 Chemical Computing Group
    • 8.51 Cimarron Software
    • 8.52 CLONDIAG Chip Technologies
    • 8.53 CodonCode Corporation
    • 8.54 CompuDrug International
    • 8.55 Compugen USA
    • 8.56 Corimbia
    • 8.57 Crucell
    • 8.58 CSIRO Bioinformatics
    • 8.59 CuraGen Corporation
    • 8.60 CyberGene
    • 8.61 Cytogen
    • 8.62 Data Unlimited International
    • 8.63 deCODE Genetics
    • 8.64 Decodon
    • 8.65 Deltagen
    • 8.66 Digilab
    • 8.67 DNA Software
    • 8.68 DNAPrint Genomics
    • 8.69 DNA Star
    • 8.70 DxS
    • 8.71 Dyax Corp
    • 8.72 Eisai
    • 8.73 Elan Corporation
    • 8.74 Electric Genetics Corporation
    • 8.75 Elusys Therapeutics
    • 8.76 Entagen
    • 8.77 Entelos
    • 8.78 Enzon Pharmaceuticals
    • 8.79 Epigenomics
    • 8.80 ePitope Informatics
    • 8.81 EraGen Biosciences
    • 8.82 European Bioinformatics Institute (EBI) Industry Programme
    • 8.83 Evolutionary BioInformatics
    • 8.84 Genamics
    • 8.85 GeneData
    • 8.86 Gene Logic
    • 8.87 Genentech
    • 8.88 Geneva Bioinformatics (GeneBio)
    • 8.89 Genmab
    • 8.90 GenOdyssee
    • 8.91 Genolyze
    • 8.92 Genomatica
    • 8.93 GenomeQuest
    • 8.94 Genomic Solutions
    • 8.95 Genomining
    • 8.96 Genovac
    • 8.97 Genzyme
    • 8.98 Geospiza
    • 8.99 GlaxoSmithKline
    • 8.100 Glycominds
    • 8.101 Health Discovery Corporation
    • 8.102 Hitachi Corporate Technology Group
    • 8.103 IBM Life Sciences
    • 8.104 ImClone Systems
    • 8.105 ImmunoGen
    • 8.106 Immunomedics
    • 8.107 Improved Outcomes Software
    • 8.108 INCOGEN
    • 8.109 Incyte Corporation
    • 8.110 Informagen
    • 8.111 Ingenuity Systems
    • 8.112 InNexus Biotechnology
    • 8.113 Insilicos
    • 8.114 Intrexon Corporation
    • 8.115 Invitrogen Corporation
    • 8.116 IO Informatics
    • 8.117 Johnson & Johnson
    • 8.118 LabVantage Solutions
    • 8.119 Lexigen
    • 8.120 Lifespan Biosciences
    • 8.121 Lion Bioscience
    • 8.122 MathEcology
    • 8.123 Matrix Science
    • 8.124 Medarex
    • 8.125 Medicel
    • 8.126 MedImmune
    • 8.127 Merus
    • 8.128 METabolic Explorer
    • 8.129 Metahelix Life Sciences
    • 8.130 Metalife
    • 8.131 Micromet
    • 8.132 Millennium Pharmaceuticals
    • 8.133 Molecular Connections
    • 8.134 Molecular Networks
    • 8.135 Molecularware
    • 8.136 MorphoSys
    • 8.137 Nexus Genomics
    • 8.138 Nonlinear Dynamics
    • 8.139 Novartis
    • 8.140 Ocimum Biosolutions
    • 8.141 OmniViz
    • 8.142 Partek
    • 8.143 PDL BioPharma
    • 8.144 Perlegen Sciences
    • 8.145 Philogen
    • 8.146 Philotec
    • 8.147 Prokaria
    • 8.148 Quantiom Bioinformatics
    • 8.149 Relevant Software
    • 8.150 Roche
    • 8.151 Rosetta Inpharmatics
    • 8.152 Sanofi-Aventis
    • 8.153 SBI Science
    • 8.154 Seascape Learning
    • 8.155 Seattle Genetics
    • 8.156 Scil Proteins
    • 8.157 Simulations Plus
    • 8.158 Spotfire
    • 8.159 Strand Life Sciences
    • 8.160 Sun Microsystems
    • 8.161 Symphogen
    • 8.162 Syngene
    • 8.163 Tahoe Informatics
    • 8.164 Tanox
    • 8.165 3rd Millennium
    • 8.166 ThromboGenics
    • 8.167 Thomson Reuters
    • 8.168 TIB MOLBIOL
    • 8.169 Trion Pharma
    • 8.170 Tripos
    • 8.171 UBI Life Sciences
    • 8.172 Viventia Biotech
    • 8.173 VizX Labs
    • 8.174 Wyeth
    • 8.175 Xcellerex
    • 8.176 Xencor
    • 8.177 Xoma
    • 8.178 Xpogen
      • INDEX OF FIGURES
    • Figure 4.1: Representation of Biotechnology Market, Geographically, 2008
    • Figure 5.1: Informatics Applications along the Drug-Discovery Value Chain
    • Figure 5.2: Functions of Bioinformatics Software in Research
    • Figure 5.3: EMBL Database Growth, 1995-2008
    • Figure 5.4: The Steps Involved in Bringing a Drug to Market
    • Figure 5.5: The Breakdown of Total Costs in New Drug Development, 2007
    • Figure 5.6: The Role of Bioinformatics in the Biotechnology Value Chain
    • Figure 5.7: Worldwide Pharmaceutical Sales and R&D Expenditures, 2000-2013
    • Figure 5.8: Worldwide Growth in IT Budget, 2000-2013
    • Figure 5.9: Worldwide Bioinformatics Market, 2000-2013
    • Figure 6.1: Steps of a Proteomics Experiment
    • Figure 6.2: Bioinformatics Architecture
      • INDEX OF TABLES
    • Table 2.1: Leading Biotechnology Companies
    • Table 2.2: Total of Domestic U.S. R&D, 2006-2013
    • Table 2.3: Global Biotechnology Market, 2007
    • Table 2.4: SIB Informatics Databases
    • Table 4.1: The U.S. Biotechnology Industry Size and Revenue, 2000-2007
    • Table 4.2: Global Biotechnology Industry Major Segments
    • Table 4.3: Genomics Sector Market Size, 2006-2013
    • Table 4.4: Total Biochip Market, 2007-2013
    • Table 4.5: Selected Competitors in the Biochip Market
    • Table 4.6: Biochip Microarray Products
    • Table 4.7: Bioinformatics Tools
    • Table 4.8: Functional Genomics Companies Building Advanced Integrated Platforms and Substantial Databases
    • Table 4.9: Companies Using New Genomic Tools
    • Table 4.10: Non-DNA-Based Chip Suppliers
    • Table 4.11: Robotics or Lab-on-a-Chip Market Sector
    • Table 4.12: Key High-throughput and Systemic Approaches in Genomic Analysis
    • Table 4.13: Pharmacogenomics Segment Players
    • Table 4.14: The Worldwide Market for Pharmacogenomics, 2006-2013
    • Table 4.15: Competitors in the SNP Genotyping Segment
    • Table 4.16: Scanning and Detection Technology Suppliers
    • Table 5.1: Data Sources and Bioinformatic Investigations
    • Table 5.2: Drivers and Challenges of the Bioinformatics Industry
    • Table 5.3: Bioinformatics Activities, Sub-Activities and Key Players
    • Table 5.4: Bioinformatics Market Size, 2006-2013
    • Table 5.5: Cheminformatics Market Size, 2006-2013
    • Table 5.6: In-silico Informatics Market Size, 2006-2013
    • Table 5.7: Bioinformatics Hardware and Systems Market Size, 2006-2013
    • Table 6.1: Alliances between IT/Telecom and Biotechnology Firms
    • Table 6.2: Types of Intellectual Property Protection for Bioinformatics Tools

Buy now >>
(managed by Piribo)

To top